Search research articles
Contact Us
Filters
Showing results (21-30 of 43) with videos related to
Page
of 5
Sort By:
Pulmonary Therapy
|
March 17, 2021
Hospital Admission and Readmission Among US Patients Receiving Umeclidinium/Vilanterol or Tiotropium as Initial Maintenance Therapy for Chronic Obstructive Pulmonary Disease
David Slade, Riju Ray, Chad Moretz, et al.
International Journal of Chronic Obstructive Pulmonary Disease
|
September 20, 2019
Real-world effectiveness of umeclidinium/vilanterol versus fluticasone propionate/salmeterol as initial maintenance therapy for chronic obstructive pulmonary disease (COPD): a retrospective cohort study
Chad Moretz, Lucie Sharpsten, Lindsay Gs Bengtson, et al.
International Journal of Chronic Obstructive Pulmonary Disease
|
October 1, 2019
Evaluation of rescue medication use and medication adherence receiving umeclidinium/vilanterol versus tiotropium bromide/olodaterol
Chad Moretz, Lindsay Gs Bengtson, Lucie Sharpsten, et al.
Oncology and Therapy
|
June 21, 2026
Real-World Actionability Analysis of Comprehensive Genomic Profiling Versus Single/Small-Gene Panels
Paul Spin, Bela Bapat, Chad Moretz, et al.
The American Journal of Managed Care
|
February 20, 2025
Medical policy determinations for pharmacogenetic tests among US health plans
Jai N Patel, Lena Chaihorsky, Olivia M Dong, et al.
The American Journal of Managed Care
|
April 17, 2015
Relationship of diabetes complications severity to healthcare utilization and costs among Medicare Advantage beneficiaries
Leslie Hazel-Fernandez, Yong Li, Damion Nero, et al.
Current Medical Research and Opinion
|
July 19, 2014
Real-world observations with prasugrel compared to clopidogrel in acute coronary syndrome patients treated with percutaneous coronary intervention in the United States
Jay P Bae, Douglas E Faries, Frank R Ernst, et al.
American Journal of Health-System Pharmacy : AJHP : Official Journal of the American Society of Health-System Pharmacists
|
March 9, 2016
Comparative resource utilization and costs for patients with acute coronary syndrome managed with percutaneous coronary intervention and treated with clopidogrel or prasugrel
Jay P Bae, Douglas E Faries, Frank R Ernst, et al.
Drugs & Aging
|
October 29, 2015
Erratum to: Antidiabetic Treatment Patterns in a Medicare Advantage Population in the United States
S Lane Slabaugh, Yihua Xu, Jane N Stacy, et al.
Drugs & Aging
|
January 10, 2015
Antidiabetic treatment patterns in a medicare advantage population in the United States
S Lane Slabaugh, Yihua Xu, Jane N Stacy, et al.
Page
of 5
Search research articles
Search
Showing results (21-30 of 43) with videos related to
Sort By:
Page
of 5
Pulmonary Therapy
|
March 17, 2021
Hospital Admission and Readmission Among US Patients Receiving Umeclidinium/Vilanterol or Tiotropium as Initial Maintenance Therapy for Chronic Obstructive Pulmonary Disease
David Slade, Riju Ray, Chad Moretz, et al.
International Journal of Chronic Obstructive Pulmonary Disease
|
September 20, 2019
Real-world effectiveness of umeclidinium/vilanterol versus fluticasone propionate/salmeterol as initial maintenance therapy for chronic obstructive pulmonary disease (COPD): a retrospective cohort study
Chad Moretz, Lucie Sharpsten, Lindsay Gs Bengtson, et al.
International Journal of Chronic Obstructive Pulmonary Disease
|
October 1, 2019
Evaluation of rescue medication use and medication adherence receiving umeclidinium/vilanterol versus tiotropium bromide/olodaterol
Chad Moretz, Lindsay Gs Bengtson, Lucie Sharpsten, et al.
Oncology and Therapy
|
June 21, 2026
Real-World Actionability Analysis of Comprehensive Genomic Profiling Versus Single/Small-Gene Panels
Paul Spin, Bela Bapat, Chad Moretz, et al.
The American Journal of Managed Care
|
February 20, 2025
Medical policy determinations for pharmacogenetic tests among US health plans
Jai N Patel, Lena Chaihorsky, Olivia M Dong, et al.
The American Journal of Managed Care
|
April 17, 2015
Relationship of diabetes complications severity to healthcare utilization and costs among Medicare Advantage beneficiaries
Leslie Hazel-Fernandez, Yong Li, Damion Nero, et al.
Current Medical Research and Opinion
|
July 19, 2014
Real-world observations with prasugrel compared to clopidogrel in acute coronary syndrome patients treated with percutaneous coronary intervention in the United States
Jay P Bae, Douglas E Faries, Frank R Ernst, et al.
American Journal of Health-System Pharmacy : AJHP : Official Journal of the American Society of Health-System Pharmacists
|
March 9, 2016
Comparative resource utilization and costs for patients with acute coronary syndrome managed with percutaneous coronary intervention and treated with clopidogrel or prasugrel
Jay P Bae, Douglas E Faries, Frank R Ernst, et al.
Drugs & Aging
|
October 29, 2015
Erratum to: Antidiabetic Treatment Patterns in a Medicare Advantage Population in the United States
S Lane Slabaugh, Yihua Xu, Jane N Stacy, et al.
Drugs & Aging
|
January 10, 2015
Antidiabetic treatment patterns in a medicare advantage population in the United States
S Lane Slabaugh, Yihua Xu, Jane N Stacy, et al.
Page
of 5